The phrase "an increasing benefit" is correct and usable in written English.
It can be used when discussing advantages or positive outcomes that are growing or becoming more significant over time.
Example: "The new policy has resulted in an increasing benefit for employees, leading to higher job satisfaction and productivity."
Alternatives: "a growing advantage" or "an expanding benefit".
The efficient allocation can be implemented by an increasing benefit during unemployment and a constant tax during employment.
We have tentatively created an unlimited category because, for the end points and constituents analyzed, increasing consumption of certain fish was associated with an increasing benefit.
A critical assumption of our model is that each sex has an increasing benefit to population growth as the sex ratio becomes biased towards the opposite sex.
Therefore, after cessation of trastuzumab treatment there is evidence of a continuing or 'carry-over' effect that results in an increasing benefit after cessation of trastuzumab.
The lack of an increasing benefit with longer durations of aspirin use was also in contrast to the previous studies of colorectal cancer.
The LCRAQ, the GSES, the ASES, the RASE and the WOC-R could be used when assessing the need for or evaluating health care interventions targeting the identified PFs and thus contribute to an increasing benefit for people with RA.
The pooled analysis of the PREEMPT 1 and 2 trials, for example, showed an increased benefit in patients who initiated OBT-A earlier compared to those who were treated 6 months later [16].
Certain fracture-patterns of MTCFs may show an increased benefit compared to others when comparing the two treatment methods, which papers 1 and 3 alluded to by sub-dividing the MTCFs into simple, wedge and comminuted/complex fractures.
Pooled univariate and multivariate analyses (N=1684) identified baseline factors associated with an increased benefit of belimumab versus placebo.
Multiple studies, including our own, have found evidence for an increased benefit of chemotherapy for mutation carriers compared with noncarriers.
In addition, 10 mg b.i.d. was predicted to offer an increased benefit in efficacy while also meeting the criteria for a laboratory end point change (hemoglobin).
